Manal Amoury

Statistics

Publications

Citations

348

H-Index

Active since

2013

Affiliations

Fraunhofer Institute for Molecular Biology and Applied Ecology(Current)

RWTH Aachen University

University of Cape Town

University Medical Center Groningen

University of Groningen

Manal Amoury is an author at Fraunhofer Institute for Molecular Biology and Applied Ecology specializing in cancer immunotherapy, targeted cancer therapy, and oncology.

Publications per year

2013–2023

Publications

Leptin Receptor Signaling in T Cells Is Required for Th17 Differentiation

Bernardo Sgarbi Reis, Kihyun Lee, Melania H. Fanok et al. · The Journal of Immunology · 2015 · 160 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model

Manal Amoury, Katharina Kolberg, Anh‐Tuan Pham et al. · Cancer Letters · 2016 · 43 citations

Medicine, Oncology, Pharmacology +13

A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein

Manal Amoury, Radoslav Mladenov, Thomas Nachreiner et al. · International Journal of Cancer · 2016 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +14

Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand

Manal Amoury, Dirk Bauerschlag, Felix Zeppernick et al. · Oncotarget · 2016 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

One Year Follow-up on the First Patient Treated with Nula-Cel: An Autologous CRISPR/Cas9 Gene Corrected CD34+ Cell Product to Treat Sickle Cell Disease

David C. Shyr, Robert Lowsky, Weston P. Miller et al. · Blood · 2023 · 24 citations

Life Sciences, Biotechnology, Genetics +15

1–5 of 8